Related Experiment Video
Updated: May 17, 2026
09:30
Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Community pharmacy practice in India: past, present and future
Subal Chandra Basak1, Dondeti Sathyanarayana
1Department of Pharmacy, Annamalai University, Annamalainagar, India.
Southern Med Review
|October 25, 2012
Summary
Indian community pharmacists primarily supply medicines, lacking patient-oriented services. Their role in medicine management may evolve with rising healthcare expenditure and domestic drug production, impacting future prospects.
Area of Science:
- Pharmaceutical Sciences
- Public Health
- Healthcare Management
Background:
- Community pharmacists are crucial for healthcare access globally, managing patient medicine needs.
- In India, their role is largely confined to medicine supply, with limited patient-focused services.
- The Indian pharmacy sector is experiencing growth in domestic medicine output and healthcare expenditure.
Purpose of the Study:
- To explore the historical development of community pharmacy in India.
- To analyze the current state of education, training, and practice of Indian community pharmacists.
- To discuss the future trajectory and potential evolution of community pharmacy in India.
Main Methods:
- Literature review on the Indian pharmacy sector.
- Analysis of historical trends in community pharmacy practice.
- Discussion of educational and training frameworks for pharmacists.
Main Results:
- Indian community pharmacy is predominantly privately owned.
- The traditional role emphasizes dispensing over clinical services.
- Significant potential exists for expanding pharmacist roles in patient care.
Conclusions:
- The evolution of Indian community pharmacy is influenced by economic and healthcare system changes.
- Enhanced education and training are vital for pharmacists to adopt patient-centered roles.
- Future prospects involve a shift towards comprehensive medicine management and improved healthcare outcomes.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:30Primary Healthcare Services
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...